Patent law was built for an era when invention was slow, costly and uncertain. But as AI compresses discovery timelines and ...

Sanofi has not had the success it was hoping for with its oral BTK inhibitors, acquired as part of its $3.7 billion buyout of Principia Biopharma, but can now point to a win for rilzabrutinib in ...

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...

The Principia School, located in Saint Louis, Missouri, is a private, coeducational day and boarding school serving students from early childhood through grade 12. Rooted in Christian Science values, ...